Neonatal Fc Receptor: From Immunity to Therapeutics
Show simple item record
| dc.contributor.author |
Yoshida, Masaru |
|
| dc.contributor.author |
Qiao, Shuo-Wang |
|
| dc.contributor.author |
Aveson, Victoria G. |
|
| dc.contributor.author |
Kuo, Timothy Ting-Chang
|
|
| dc.contributor.author |
Baker, Kristi Dorothy
|
|
| dc.contributor.author |
Lencer, Wayne Isaac
|
|
| dc.contributor.author |
Blumberg, Richard Steven
|
|
| dc.date.accessioned |
2011-04-23T14:48:57Z |
|
| dc.date.issued |
2010 |
|
| dc.identifier.citation |
Kuo, Timothy T., Kristi Baker, Masaru Yoshida, Shuo-Wang Qiao, Victoria G. Aveson, Wayne I. Lencer, and Richard S. Blumberg. 2010. Neonatal Fc receptor: from immunity to therapeutics. Journal of Clinical Immunology 30(6): 777-789. |
en_US |
| dc.identifier.issn |
0271-9142 |
en_US |
| dc.identifier.uri |
http://nrs.harvard.edu/urn-3:HUL.InstRepos:4874790 |
|
| dc.description.abstract |
The neonatal Fc receptor (FcRn), also known as the Brambell receptor and encoded by Fcgrt, is a MHC class I like molecule that functions to protect IgG and albumin from catabolism, mediates transport of IgG across epithelial cells, and is involved in antigen presentation by professional antigen presenting cells. Its function is evident in early life in the transport of IgG from mother to fetus and neonate for passive immunity and later in the development of adaptive immunity and other functions throughout life. The unique ability of this receptor to prolong the half-life of IgG and albumin has guided engineering of novel therapeutics. Here, we aim to summarize the basic understanding of FcRn biology, its functions in various organs, and the therapeutic design of antibody- and albumin-based therapeutics in light of their interactions with FcRn. |
en_US |
| dc.language.iso |
en_US |
en_US |
| dc.publisher |
Springer US |
en_US |
| dc.relation.isversionof |
doi:10.1007/s10875-010-9468-4 |
en_US |
| dc.relation.hasversion |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970823/pdf/ |
en_US |
| dash.license |
LAA |
|
| dc.subject |
FcRn |
en_US |
| dc.subject |
Fcgrt |
en_US |
| dc.subject |
Brambell |
en_US |
| dc.subject |
IgG |
en_US |
| dc.subject |
Fc |
en_US |
| dc.subject |
albumin |
en_US |
| dc.subject |
transcytosis |
en_US |
| dc.subject |
transport |
en_US |
| dc.subject |
recycling |
en_US |
| dc.title |
Neonatal Fc Receptor: From Immunity to Therapeutics |
en_US |
| dc.type |
Journal Article |
en_US |
| dc.description.version |
Version of Record |
en_US |
| dc.relation.journal |
Journal of Clinical Immunology |
en_US |
| dash.depositing.author |
Kuo, Timothy Ting-Chang
|
|
| dc.date.available |
2011-04-23T14:48:57Z |
|
| dash.affiliation.other |
HMS^Medicine-Brigham and Women's Hospital |
en_US |
| dash.affiliation.other |
HMS^Pediatrics-Children's Hospital |
en_US |
Files in this item
This item appears in the following Collection(s)
Show simple item record
Contact administrator regarding this item (to report mistakes or request changes)